Patent Waiver Wouldn't Speed Making COVID-19 Vaccines in Greece
Αssociated Press 36 year-old Vasilis Tsipiras waits to receive his first dose of the of the AstraZeneca COVID-19 vaccine, at a vaccination center in Piraeus, near Athens, Thursday, April 29, 2021. (AP Photo/Petros Giannakouris) 5/7/2021 Αssociated Press ATHENS – Even if companies making the COVID-19 vaccine waive the patent for making them – at a cost – a facility in Greece wouldn't be up and running until late in 2022, even if started immediately. That was the assessment from the President of the Panhellenic Union of Pharmaceutical Industries, Theodoros Tryfon, who told ...